Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)

SHA:603858 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,432	818.81	694.13	2,149	1,218	1,470
Short-Term Investments	-	-	-	-	-	3.6
Trading Asset Securities	708.01	403.75	354.09	726.45	498.17	386.45
Cash & Short-Term Investments	2,140	1,223	1,048	2,875	1,716	1,860
Cash Growth	56.71%	16.63%	-63.54%	67.56%	-7.73%	-16.07%
Accounts Receivable	1,152	1,258	1,887	1,905	2,171	2,639
Other Receivables	114.74	114.03	152.16	164.69	200.57	324.83
Receivables	1,267	1,372	2,039	2,070	2,372	2,964
Inventory	4,410	4,624	4,930	3,789	3,834	2,767
Other Current Assets	274.1	317.76	263.32	257.42	430.37	395.99
Total Current Assets	8,091	7,537	8,281	8,991	8,352	7,986
Property, Plant & Equipment	5,041	5,664	6,000	6,301	5,919	5,343
Long-Term Investments	1,525	1,525	1,496	1,449	1,433	1,437
Goodwill	620.04	620.04	1,473	2,063	5,133	5,122
Other Intangible Assets	792.91	809.53	949.17	1,074	1,171	1,241
Long-Term Accounts Receivable	-	-	-	16.75	23.32	16.75
Long-Term Deferred Tax Assets	387.55	389.32	368.19	221.38	220.68	170.57
Long-Term Deferred Charges	1,768	1,699	1,386	1,125	978.44	870.21
Other Long-Term Assets	1,612	1,085	938.55	710.55	754.32	699.33
Total Assets	19,837	19,329	20,892	21,952	23,986	22,886
Accounts Payable	2,632	2,846	2,497	2,398	2,495	1,938
Accrued Expenses	133.13	1,637	2,286	2,318	1,903	2,023
Short-Term Debt	491.48	486.46	240.12	638.76	1,295	2,561
Current Portion of Long-Term Debt	1,315	1,123	737.93	307.04	307.42	68.9
Current Portion of Leases	-	46.04	64.32	53.69	14.96	-
Current Income Taxes Payable	142.61	37.3	75.6	95.54	118.67	136.94
Current Unearned Revenue	263.8	215.76	238	376.52	242.4	335.7
Other Current Liabilities	2,134	710.86	717.29	773.22	786.25	749.57
Total Current Liabilities	7,112	7,102	6,856	6,961	7,162	7,813
Long-Term Debt	2,147	1,986	2,098	2,127	1,902	824.32
Long-Term Leases	181.06	74.62	154.58	170.37	19.14	-
Long-Term Unearned Revenue	267.49	283.59	312.29	330.55	345.63	340.29
Long-Term Deferred Tax Liabilities	74.68	71.24	90.52	87.51	106.22	97.36
Other Long-Term Liabilities	3.02	3.02	5.07	-	-	-
Total Liabilities	9,786	9,520	9,516	9,677	9,536	9,075
Common Stock	1,106	1,106	1,106	1,106	1,142	1,142
Additional Paid-In Capital	2,493	2,493	2,493	2,494	3,392	3,385
Retained Earnings	7,626	7,318	8,008	8,751	10,806	10,122
Treasury Stock	-760.13	-712.38	-1.85	-	-934	-934
Comprehensive Income & Other	10.29	11.23	11.84	12.13	19.3	0.5
Total Common Equity	10,475	10,216	11,617	12,363	14,425	13,715
Minority Interest	-424.09	-408.38	-240.98	-87.58	25.17	96.19
Shareholders' Equity	10,051	9,808	11,376	12,275	14,450	13,811
Total Liabilities & Equity	19,837	19,329	20,892	21,952	23,986	22,886
Total Debt	4,135	3,716	3,295	3,297	3,539	3,455
Net Cash (Debt)	-1,995	-2,493	-2,247	-421.83	-1,823	-1,595
Net Cash Per Share	-1.86	-2.30	-2.03	-0.38	-1.65	-1.44
Filing Date Shares Outstanding	1,058	1,061	1,095	1,106	1,106	1,106
Total Common Shares Outstanding	1,058	1,061	1,106	1,106	1,106	1,106
Working Capital	978.56	435	1,425	2,030	1,190	172.57
Book Value Per Share	9.90	9.63	10.50	11.18	13.04	12.40
Tangible Book Value	9,062	8,787	9,195	9,225	8,121	7,351
Tangible Book Value Per Share	8.57	8.28	8.31	8.34	7.34	6.65
Buildings	-	4,891	5,036	5,195	3,211	2,455
Machinery	-	2,330	2,034	1,825	1,578	1,433
Construction In Progress	-	1,132	1,243	1,235	2,821	2,918

Source: S&P Global Market Intelligence. Standard template. Financial Sources.